BARING ASSET MANAGEMENT Ltd reduced its position in shares of Albemarle Corporation (NYSE:ALB) by 40.6% during the second quarter, Holdings Channel reports. The fund owned 141,948 shares of the specialty chemicals company’s stock after selling 96,840 shares during the period. Albemarle Corporation comprises about 1.0% of BARING ASSET MANAGEMENT Ltd’s investment portfolio, making the stock its 22nd largest position. BARING ASSET MANAGEMENT Ltd’s holdings in Albemarle Corporation were worth $14,982,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in Albemarle Corporation by 2,805.3% in the first quarter. BlackRock Inc. now owns 8,310,717 shares of the specialty chemicals company’s stock worth $877,947,000 after buying an additional 8,024,668 shares during the last quarter. Vanguard Group Inc. increased its stake in Albemarle Corporation by 6.3% in the first quarter. Vanguard Group Inc. now owns 12,287,799 shares of the specialty chemicals company’s stock worth $1,298,083,000 after buying an additional 725,702 shares during the last quarter. Jennison Associates LLC increased its stake in Albemarle Corporation by 14.0% in the first quarter. Jennison Associates LLC now owns 5,705,825 shares of the specialty chemicals company’s stock worth $602,763,000 after buying an additional 702,388 shares during the last quarter. KAMES CAPITAL plc increased its stake in Albemarle Corporation by 2,716.6% in the first quarter. KAMES CAPITAL plc now owns 322,788 shares of the specialty chemicals company’s stock worth $34,099,000 after buying an additional 311,328 shares during the last quarter. Finally, Barings LLC bought a new stake in Albemarle Corporation during the first quarter worth about $29,862,000. Hedge funds and other institutional investors own 86.22% of the company’s stock.

Shares of Albemarle Corporation (ALB) opened at 112.30 on Wednesday. The company has a 50-day moving average of $114.08 and a 200 day moving average of $107.15. The firm has a market capitalization of $12.41 billion, a PE ratio of 14.36 and a beta of 1.59. Albemarle Corporation has a 12-month low of $75.11 and a 12-month high of $123.48.

Albemarle Corporation (NYSE:ALB) last announced its quarterly earnings data on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.02. The business had revenue of $737.25 million for the quarter, compared to the consensus estimate of $735.50 million. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. Albemarle Corporation’s quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the company posted $0.93 earnings per share. On average, analysts predict that Albemarle Corporation will post $4.36 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Friday, September 15th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.28 annualized dividend and a dividend yield of 1.14%. Albemarle Corporation’s payout ratio is 16.41%.

ILLEGAL ACTIVITY WARNING: “Albemarle Corporation (ALB) Position Cut by BARING ASSET MANAGEMENT Ltd” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/16/albemarle-corporation-alb-position-cut-by-baring-asset-management-ltd.html.

A number of equities research analysts recently issued reports on ALB shares. Zacks Investment Research upgraded shares of Albemarle Corporation from a “hold” rating to a “buy” rating and set a $121.00 target price for the company in a report on Friday, July 7th. Robert W. Baird reiterated an “outperform” rating and set a $135.00 price objective (up from $125.00) on shares of Albemarle Corporation in a research note on Tuesday, July 18th. They noted that the move was a valuation call. BidaskClub downgraded shares of Albemarle Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Needham & Company LLC reiterated a “buy” rating and set a $36.00 price objective on shares of Albemarle Corporation in a research note on Thursday, June 29th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $120.00 price objective on shares of Albemarle Corporation in a research note on Friday, June 16th. Seven analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $106.69.

In other news, EVP Karen G. Narwold sold 20,000 shares of the firm’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $108.16, for a total value of $2,163,200.00. Following the sale, the executive vice president now owns 45,120 shares in the company, valued at $4,880,179.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Douglas L. Maine sold 10,000 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $107.94, for a total transaction of $1,079,400.00. Following the completion of the sale, the director now owns 24,150 shares in the company, valued at approximately $2,606,751. The disclosure for this sale can be found here. In the last 90 days, insiders sold 105,000 shares of company stock worth $11,499,850. 0.74% of the stock is currently owned by corporate insiders.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Stock Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related stocks with our FREE daily email newsletter.